A launch that changed the quarter
Remedy Entertainment’s latest business review turns CONTROL Resonant from a successful release into a company-level inflection point. The sequel launched digitally worldwide on September 24, 2026, and by October 15, the date of its physical release, it had passed one million copies sold. Remedy says that made it the fastest-selling game in the studio’s history .
The financial effect arrived quickly. For July through September 2026, Remedy reported revenue of €39.6 million, up 226.0% from €12.2 million in the same quarter of 2025 . That is the “tripling” headline in its simplest form, but the more important point is timing: only preorders and the first seven days of CONTROL Resonant sales were included in the quarter . In other words, the launch had only begun to show up in the books.
CEO Jean-Charles Gaudechon framed the release as “a defining milestone” for Remedy, not only because of the sales figure, but because CONTROL Resonant is the studio’s first self-published game at this scale on its own CONTROL intellectual property . That distinction matters. Remedy is no longer just collecting development fees or relying on partners to carry publishing weight; it is assuming more risk and, when a game lands, keeping more strategic control over the upside.
The numbers behind the surge
The Q3 line items show how concentrated the quarter was around the new release. Game sales and royalties reached €35.3 million, compared with €6.0 million a year earlier, while development fees totaled €4.3 million, down from €6.1 million . Those development fees came from the Max Payne 1&2 remake, which Remedy is developing for Rockstar Games, and the final development-fee accrual for CONTROL Resonant under the Annapurna agreement .
Profitability also swung sharply. Remedy posted EBITDA of €6.8 million, up from €0.7 million, and operating profit of €0.6 million, compared with an operating loss of €16.4 million in Q3 2025 . The operating margin was 1.5%, versus negative 135.1% a year earlier . Several reports highlighted the same turn back into operating profit, underscoring how visible CONTROL Resonant’s launch has become in Remedy’s public financial profile .
That said, the profit swing should not be read as pure margin expansion from one hit game. Remedy’s comparison quarter in 2025 included a €14.9 million non-cash impairment related to FBC: Firebreak, and the 2026 quarter also carried launch-period costs . Remedy said marketing activity peaked around the release and described the campaign as the largest marketing investment in its history . As a self-publisher, it is also directly carrying platform fees and royalty expenses, including Annapurna’s share of CONTROL Resonant revenue until initial investments are recouped .
Cash flow tells a more cautious story than revenue. Operating cash flow for Q3 was slightly negative at €0.1 million, compared with positive €11.3 million a year earlier . Tbreak noted that this reflected the timing of payments, with receivables rising because some game-sales cash will arrive in later periods . That does not undermine the sales result, but it is a useful reminder that revenue recognition, cash collection, and profit are not the same thing.
Why one million copies matters
Selling one million copies in roughly three weeks is not just a vanity milestone for Remedy. It establishes CONTROL Resonant as the company’s fastest-selling title and gives the CONTROL franchise a larger commercial base than it had before launch . The original Control had already become one of Remedy’s defining modern properties, but Resonant appears to have widened the audience rather than merely selling to the same core fan base.
Remedy said close to 50% of CONTROL Resonant players were new to CONTROL, based on analytics data . That is one of the most important details in the update. A sequel can generate a short-term revenue spike by activating existing fans, but a sequel that brings in new players can reset the size of the franchise. The company also reported 2.4 million outstanding wishlists, which points to a large pool of potential buyers still outside the first wave .
Geography adds another layer to the story. The United States was the game’s largest market on both PC and consoles, accounting for nearly half of sales by revenue and units . On PC, Chinese-speaking regions and the United Kingdom followed; on consoles, the United Kingdom and Canada ranked behind the United States, while Brazil also reached the top three by console units . Game World Observer emphasized that this spread reflects strong traction beyond the traditional core markets, particularly given Remedy’s larger outreach to Asia and Latin America .
The reception data helps explain the momentum. Remedy cited a combined Metacritic rating of 83, a Metacritic user score of 8.8 out of 10, a 91% positive Steam rating, and a 4.7 out of 5 average user rating on PlayStation 5, with those ratings based on November 2 data . The company also said players voted CONTROL Resonant the top new game of September 2026 in PlayStation’s Players’ Choice poll . Those are useful launch signals because a premium single-player game often depends on word of mouth after the first marketing burst.
Self-publishing raises both the ceiling and the pressure
CONTROL Resonant is also a test of Remedy’s evolving business model. In the past, the studio’s finances were more heavily shaped by development-fee structures and publishing partners. With Resonant, Remedy is demonstrating that it can launch a major game under its own publishing umbrella and generate a quarter that exceeds its entire 2025 revenue pace. For the first nine months of 2026, revenue reached €62.9 million, already above Remedy’s full-year 2025 revenue of €59.5 million .
The trade-off is that Remedy must carry costs that a traditional publisher might otherwise absorb. Platform fees, marketing, royalty-sharing mechanics, and depreciation of capitalized development costs all flow through the income statement . That is why a blockbuster-looking revenue jump translated into only €0.6 million of operating profit for the quarter . The upside is real, but so is the accounting burden of owning the launch.
The broader pipeline matters too. Remedy listed CONTROL Resonant in post-launch development, the Max Payne 1&2 remake in full production, and a new self-published project at production-readiness stage . The company’s full-year outlook remained unchanged: it expects 2026 revenue and EBITDA to increase from the previous year . But Gaudechon also warned that sales over the remainder of the year will ultimately define Remedy’s 2026 financial result .
The bottom line
CONTROL Resonant has already done what Remedy needed it to do at launch: it sold quickly, expanded the CONTROL audience, delivered record-like quarterly revenue, and gave the studio proof that its self-publishing ambitions can work at scale. The Oldest House may not print money, but in Q3 it clearly installed a revenue multiplier.
The next test is durability. One million copies in three weeks made CONTROL Resonant Remedy’s fastest seller; 2.4 million outstanding wishlists suggest room to grow; and strong user scores give the game a better chance of converting late buyers . If post-launch support and disciplined marketing keep the momentum alive through the holiday period, CONTROL Resonant may be remembered not just as a hit sequel, but as the release that changed Remedy’s commercial footing.
Comments
Be the first to comment.